Praxsyn Corporation (PXYN) 0.0025 $PXYN Update to Letter

New Post Public Reply Private Reply Replies (0) Message Board

Sep 23, 2016 at 7:06 AM

Praxsyn Corporation (PXYN) 0.0025 $PXYN

Update to Letter to Praxsyn Corporation's Shareholders from its Chairman and CEO
GlobeNewswire - Tue Jun 21, 8:00AM CDT
Praxsyn Corporation (OTC

XYN) published a letter on April 15, 2016 to its shareholders from Greg Sundem, its Chairman and Chief Executive Officer. This letter is from Mr. Sundem to update the Company's shareholders as to the Company's business and operations as of this date.

Letter to Praxsyn Corporation's Shareholders from its Chairman and CEO
GlobeNewswire - Fri Apr 15, 1:28PM CDT
Praxsyn Corporation (OTCQB

XYN) announces today it will publish a Letter to its shareholders from its Chairman and CEO regarding the company's business and operations.

Technical Data and the Price Movement -- Analyst Review of Praxsyn, Baristas Coffee Company, Soligenix and Acacia Diversified Holdings
ACCESSWIRE - Mon Feb 01, 8:20AM CST
NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Praxsyn Corp. (OTC: PXYN), Baristas Coffee Company Inc. (OTC: BCCI), Soligenix Inc. (OTC: SNGX) and Acacia Diversified Holdings Inc. (OTC: ACCA). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

Market Influences That Drive Equities Forward - New Research on American Green, Praxsyn, Norsk Hydro and Soligenix
ACCESSWIRE - Thu Jan 21, 8:03AM CST
NEW YORK, NY / ACCESSWIRE / January 21, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: American Green Inc. (OTC: ERBB), Praxsyn Corp. (OTC: PXYN), Norsk Hydro ASA (OTC: NHYDY) and Soligenix Inc. (OTC: SNGX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

Praxsyn Corporation Launches New Website
GlobeNewswire - Mon Sep 21, 7:04PM CDT
Praxsyn Corporation (OTCQB

XYN), a diversified holding company that finds alternative solutions to fit the needs and goals of their strategic relationships, is pleased to announce the launch of its new website www.praxsyn.com. According to Edward Kurtz, CEO of Praxsyn, the new website is aimed at highlighting the company's strategic vision for growth and expansion over the next few years, and beyond.

Praxsyn Corporation Announces New Chief Financial Officer
GlobeNewswire - Mon Jul 27, 9:10AM CDT
Praxsyn Corporation's (OTCQB

XYN) today announced that Justin Cary, 33, has been appointed by the Board of Directors as the company's Chief Financial Officer (CFO) effective immediately.

Praxsyn Corporation Growth Requires Expansion Into New Space
GlobeNewswire - Thu Jul 16, 9:04AM CDT
Praxsyn Corporation (OTCQB

XYN) is pleased to announce that it has finalized a lease on a new building for its pharmacy lab and billing services with expansion efforts now underway. The new space will allow Praxsyn's wholly owned subsidiary, Mesa Pharmacy (Mesa), a medication and service provider for medical practitioners, to significantly increase the size of its pharmacy lab, providing capacity for new equipment, a more diverse list of offered medications, and to continue the growth of its pharmacy staff. The expansion will also provide additional space for another wholly-owned subsidiary, NexGen Med Solutions (NexGen), a billing and collections company.

Praxsyn's 2015 Anticipated Business Strategies
GlobeNewswire - Mon Jun 08, 12:03PM CDT
Praxsyn Corporation's (OTCQB

XYN) anticipated business plan for 2015 is to acquire a sister subsidiary retail community pharmacy and to purchase additional pharmacies. Mesa is also in the early stages of developing a program to supply medications and products to diabetic patients and anticipates the commencement of filling prescriptions by the end of the third quarter of 2015.

Praxsyn Announces New Business Associate Agreement With Products for Doctors
GlobeNewswire - Tue Apr 14, 8:15AM CDT
Praxsyn Corporation's (OTCQB

XYN) wholly owned subsidiary, Mesa Pharmacy Inc. (Mesa), entered into a Business Associate Agreement with Products for Doctors for marketing and other services on January 23, 2015. The non-exclusive agreement between Products for Doctors and Mesa facilitates the marketing of Mesa's products to medical providers throughout California.

Praxsyn Announces New Pharmacist in Charge for Mesa Pharmacy
GlobeNewswire - Mon Mar 09, 1:55PM CDT
Praxsyn Corporation's (OTCQB

XYN) wholly owned subsidiary, Mesa Pharmacy Inc. (Mesa), announced today that, as of February 12, 2015, Dr. Amy Lee (Hawkins) Summers, Pharm, D., has joined the company as its new pharmacist in charge (PIC) and director of pharmacy.

Praxsyn Corporation Announces Mesa Pharmacy Has Commenced Processing of PPO Prescriptions
GlobeNewswire - Thu Dec 18, 11:56AM CST
Praxsyn Corporation (OTCQB

XYN), the parent company of Mesa Pharmacy, today announced that it has begun to process PPO prescriptions. Mesa Pharmacy is dedicated to providing medical practitioners with medications for patients through this move into the PPO network with its new and advanced products.

Praxsyn Corporation Now Licensed to Dispense Medication in 22 States
GlobeNewswire - Fri Dec 12, 9:02AM CST
Praxsyn Corporation (OTCQB

XYN), today announced that its wholly owned subsidiary, Mesa Pharmacy Inc., a medication and service provider for medical practitioners, has continued to make progress towards its goal of dispensing its customized medications nationwide. "We believe in our products and we are excited to help patients nationwide," said Andrew Do, Chief Pharmacist, Mesa Pharmacy. The company is now licensed to dispense its medications in the following 22 states:

Praxsyn Corporation Announces Change of Domicile From Illinois to Nevada and Appointment of New Board Members
GlobeNewswire - Wed Nov 05, 8:30AM CST
Praxsyn Corporation (OTCQB

XYN) announced today that the majority of its shareholders have voted to change domiciles from the state of Illinois to Nevada. Praxsyn Corporation shareholders entitled to vote authorized the change of domicile via their majority written consent due to: a) Nevada's favorable corporate laws; b) lower corporate income taxes; and c) easily accessible corporate filings through the Nevada Secretary of State's web portal.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Windward Bio Surges 68% in Nasdaq Debut

By Ryan Hughes Updated Nov 13, 2026 Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Retirement Dreams Dashed: 61% Withdraw Early

By Olivia Taylor Updated Nov 14, 2026 Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....